Sign in

Florent Morio

@florentmorio.bsky.social
96 followers 37 following 7 posts

Professor, Nantes University Hospital, France. FECMM. Mycoses, antifungal resistance, One Health. @CHUnantes @NantesUniv. Dad x2. Views my own.

PostsRepliesMedia
Reposted by Florent Morio
Clement Tsui PhD 🇭🇰 🇨🇦 @clementsui.bsky.social · 06/09/2025
Name changes for fungi of medical importance, 2022–2024 | Journal of Clinical Microbiology journals.asm.org/doi/10.1128/...
journals.asm.org
Name changes for fungi of medical importance, 2022–2024 | Journal of Clinical Microbiology
Since fungal identification methods based on examination of morphological and phenotypic features are complicated by the astonishing diversity of organisms capable of causing human infections especial...
062
Reposted by Florent Morio
bioRxivpreprint @biorxivpreprint.bsky.social · 01/05/2025
Small pangenome of Candida parapsilosis reflects overall low intraspecific diversity www.biorxiv.org/content/10.1101/202…
001
Reposted by Florent Morio
phy_papers @phypapers.bsky.social · 02/05/2025
Small pangenome of Candida parapsilosis reflects overall low intraspecific diversity www.biorxiv.org/content/10.1101/202…
001
Reposted by Florent Morio
Alexander V. Veselov 😷🎮 @alexxxmd.bsky.social · 01/07/2025
Candida parapsilosis and echinocandins: should the clinical laboratory drop anidulafungin Etest from the susceptibility testing panel? Roya Vahedi-Shahandashti, et al. Antimicrobial Agents and Chemotherapy, 2025 doi.org/10.1128/aac....
doi.org
Candida parapsilosis and echinocandins: should the clinical laboratory drop anidulafungin Etest from the susceptibility testing panel? | Antimicrobial Agents and Chemotherapy
Candidemia remains a prevalent and life-threatening infection, leading to considerable morbidity and mortality, particularly in critically ill patients (1, 2). Invasive candidiasis affects over 250,00...
011
Reposted by Florent Morio
Clement Tsui PhD 🇭🇰 🇨🇦 @clementsui.bsky.social · 25/07/2025
Checkout this article I found at PLOS: dx.plos.org/10.1371/jour...
dx.plos.org
Myco-Ed: Mycological curriculum for education and discovery
Fungi are important and hyperdiverse organisms, yet chronically understudied. Most fungal clades have no reference genomes, impeding our understanding of their ecosystem functions and use as solutions...
092
Reposted by Florent Morio
bioRxiv Genomics @biorxiv-genomic.bsky.social · 01/05/2025
Small pangenome of Candida parapsilosis reflects overall low intraspecific diversity www.biorxiv.org/content/10.1101/202…
011
Reposted by Florent Morio
Caitlin Kowalski @caitlinkowa.bsky.social · 14/04/2025
Excited to share that our story on S. aureus antagonism by Malassezia is live today in Current Biology! The paper has changed a lot since the preprint with the very exciting addition of having identified the antimicrobial effector generated by M. sympodialis. authors.elsevier.com/c/1kwzj3QW8S...
authors.elsevier.com
15416
Reposted by Florent Morio
ecmmcandidaiv.bsky.social @ecmmcandidaiv.bsky.social · 08/04/2025
ECMM Candida IV Study is still open for participation Global study on non-albicans candidemia Requirements: 🔬Clinical data + isolates (no limit per site) 📅Apr 2024-Sep 2025 📦Ship isolates in one batch at study end 💰Case-based reimbursement available @martinhoenigl.bsky.social
076
Florent Morio @florentmorio.bsky.social · 13/04/2025
🆕️All you need to know about antifungal resistance in non fumigatus Aspergillus species. Great article led by Elie Djenontin and Eric Dannaoui. Glad to contribute 🙏 Just published in Mycoses pubmed.ncbi.nlm.nih.gov/40219727/
pubmed.ncbi.nlm.nih.gov
Antifungal Resistance in Non-fumigatus Aspergillus Species - PubMed
This review provides an in-depth exploration of antifungal resistance in non-fumigatus Aspergillus species, mainly focusing on acquired resistance. The available data have been compiled and sometimes ...
011
Reposted by Florent Morio
Christopher Strebel @c-strebel.bsky.social · 01/04/2025
WHO reports on the critical lack of medicines and diagnostic tools for invasive fungal diseases. #PublicHealth www.who.int/news/item/01...
who.int
WHO issues its first-ever reports on tests and treatments for fungal infections
WHO's reports addressing the critical lack of medicines and diagnostic tools for invasive fungal diseases, shows urgent need for innovative research and development (R&D) to close the gaps. Fungal dis...
037
Reposted by Florent Morio
Contagion® @contagionlive.bsky.social · 01/04/2025
The organization's reports discuss the small number of newly approved treatments, the limited, late-stage antifungal pipeline, and challenges around diagnostics for this class of infections. #IDsky #Medsky
contagionlive.com
WHO Issues First Reports on Diagnostics, Therapies For Fungal Infections
The organization's reports discuss the small number of newly approved treatments, the limited, late-stage antifungal pipeline, and challenges around diagnostics for this class of infections.
01914
Reposted by Florent Morio
Martin Hoenigl @martinhoenigl.bsky.social · 02/04/2025
👉Participate in the ECMM Candida IV Study 🌍wide study on candidemia caused by non-albicans Candida Requirement: clinical data & isolate (not req for C.auris) Observation period: 04/2024 - 09/2025 Interested? Email stella.wolfgruber@medunigraz.at
033
Reposted by Florent Morio
biomickwatson @biomickwatson.bsky.social · 29/03/2025
Two journals tried paying peer reviewers and found increased acceptance, earlier reports, and no change in quality. WHAT A SURPRISE!
1146
Florent Morio @florentmorio.bsky.social · 18/02/2025
Thrilled to see our work featured on @ASMicrobiology's podcast, Best Papers of AAC 2024! 🎉🔬 Thanks to #AAC for the spotlight! 🎧 Listen to the podcast: www.youtube.com/watch?v=gh0D... 📄 Read the paper: journals.asm.org/doi/10.1128/... #UR1155 #NantesUniversité
youtube.com
Best Papers of AAC, 2024 - Editors in Conversation AAC Edition
YouTube video by American Society for Microbiology
010
Reposted by Florent Morio
Clement Tsui PhD 🇭🇰 🇨🇦 @clementsui.bsky.social · 12/02/2025
Very interesting! Azole resistant #Candida auris in locusts. www.biorxiv.org/content/10.1...
biorxiv.org
South African brown locusts, Locustana pardalina, hosts fluconazole resistant Candidozyma (Candida) auris (Clade III)
The environmental niche and mode of transmission from the environment to humans of the emerging pathogenic yeast, Candidozyma ( Candida ) auris is a subject of speculation, with hypotheses including a...
031
Florent Morio @florentmorio.bsky.social · 02/02/2025
🚨 One more outbreak of FLC-R Candida parapsilosis described in the UK. @bramspr.bsky.social pubmed.ncbi.nlm.nih.gov/39878027/
pubmed.ncbi.nlm.nih.gov
Cluster of clonal fluconazole-resistant Candida parapsilosis harbouring Y132F mutation in ERG11 gene in a neonatal ICU in the UK - PubMed
Cluster of clonal fluconazole-resistant Candida parapsilosis harbouring Y132F mutation in ERG11 gene in a neonatal ICU in the UK
042
Reposted by Florent Morio
Ilan Schwartz @germhuntermd.bsky.social · 23/01/2025
Health researchers alarmed as Trump admin pauses travel, communications “Everything is basically in chaos. And frankly everyone is terrified. We’ve never seen anything like this. This is like a meteor just crashed into all of our cancer centers and research areas.” Gift access: wapo.st/4jI1Wuj
wapo.st
Health researchers alarmed as Trump administration pauses travel, communications
The halt has frozen research grants, meetings and key health updates. “Everything is basically in chaos,” said one cancer researcher.
12411
Reposted by Florent Morio
Melody Schreiber @melodyschreiber.com · 24/01/2025
BREAKING: US health agency employees are now banned from nearly all travel and certain agencies and programs have been ordered to stop issuing new contracts and grants until further notice. www.theguardian.com/us-news/2025...
theguardian.com
Travel, grant and funding cuts ‘stifling’ US health agencies in new Trump era
Halts to external communications, publishing reports and reviewing and approving research a ‘dramatic shift’
812069
Reposted by Florent Morio
Thanh Neville, MD, MSHS @thanh-neville.bsky.social · 25/01/2025
One of my friends has a grant from the #FDA to look at disparities in clinical trial research and just submitted a manuscript with the findings. She was told today by the collaborators from the #FDA to rescind it. #Censorhip has started, we are living in authoritarian government.
reuters.com
US FDA drops web pages on improving clinical trial diversity
The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and devices in diverse populations as part of a purge of diversity, equity and inclusion efforts at U.S. health agencies.
34788394
Florent Morio @florentmorio.bsky.social · 28/01/2025
www.biorxiv.org/content/10.1...
biorxiv.org
South African brown locusts, Locustana pardalina, hosts fluconazole resistant Candidozyma (Candida) auris (Clade III)
The environmental niche and mode of transmission from the environment to humans of the emerging pathogenic yeast, Candidozyma ( Candida ) auris is a subject of speculation, with hypotheses including a...
000
Reposted by Florent Morio
Ilan Schwartz @germhuntermd.bsky.social · 11/01/2025
Epidemiology and Prognostic Factors Associated With Mold-Positive Blood Cultures: 10-Year Data From a French Prospective Surveillance Program (2012–2022) academic.oup.com/cid/advance-...
Visual abstract
1228
Reposted by Florent Morio
Geraldine Butler @yeastpi.bsky.social · 03/12/2024
Enjoying presenting our work on European populations of the lager yeast parent Saccharomyces eubayanus in Coquimbo, Chile SOMICH. Thanks to @fcocubillosr.bsky.social
072
Reposted by Florent Morio
Geraldine Butler @yeastpi.bsky.social · 04/12/2024
Early deadline for ECFG17 fast approaching! Come to Dublin in Spring 2025.
087
Reposted by Florent Morio
Alexander Lorenz @lorenzlab.bsky.social · 13/12/2024
There is competitive #PhD funding for 4 years (eligibility criteria apply) to do a project on the human pathogen Candidozyma (Candida) auris dissecting the genetic basis of its antimicrobial resistance #AMR www.findaphd.com/phds/project... - pls repost
findaphd.com
EASTBIO: Harnessing Transposon Mutagenesis to Dissect Antifungal Drug Resistance in the Fungal “Superbug” Candidozyma auris at University of Aberdeen on FindAPhD.com
PhD Project - EASTBIO: Harnessing Transposon Mutagenesis to Dissect Antifungal Drug Resistance in the Fungal “Superbug” Candidozyma auris at University of Aberdeen , listed on FindAPhD.com
046
Reposted by Florent Morio
Rebecca Drummond 🍄 @therad-lab.bsky.social · 16/12/2024
There's still time to apply for this postdoc position in our lab. Ideally suited to someone wanting to develop some independent research, we have lots of new projects to select from! #immunosky 🧪
02126
Reposted by Florent Morio
IRB Barcelona @irbbarcelona.org · 25/11/2024
🦠 Threats from the #Candida parapsilosis complex: the surge of multidrug resistance and a hotbed for new emerging pathogens. 📝 @tonigabaldon.bsky.social, @gabaldonlab.bsky.social 📔 #Microbiology and #MolecularBiology Reviews 📌https://doi.org/10.1128/mmbr.00029-23 #IRBScience 🧪
074
Reposted by Florent Morio
Norman van Rhijn @normanvanrhijn.bsky.social · 28/11/2024
🚨Please share🚨 I’m hiring a PhD student to start Sep 2025 on an exciting project on fungal pathogens🍄‍🟫, soil health and microbiomes, together with dr. Filipa Cox and @knightjar.bsky.social If you have any good candidates, please let them contact me directly. www.findaphd.com/phds/project...
findaphd.com
02937
Reposted by Florent Morio
NEJM.org @nejm.org · 10/12/2024
On this day in 1981, a landmark paper in NEJM described four patients with evidence of immunodeficiency associated with PJP pneumonia, disseminated CMV, and Kaposi sarcoma. The disease would come to be known as HIV/AIDS. Revisit the paper: nej.md/41iekKD #MedSky #IDSky
Published on This Day in 1981.  
Pneumocystis carinii Pneumonia and Mucosal Candidiasis in Previously Healthy Homosexual Men — Evidence of a New Acquired Cellular Immunodeficiency  

An illustration showing the reproductive cycle of human immunodeficiency virus type 1 (HIV-1) and sites of action of the major classes of antiretroviral medications.  

The NEJM identity sits at the bottom.
12474217